Skip to main content
Caplight Logo









NaDeNo Nanoscience

NaDeNo Nanoscience

Private
TrondheimHealthcare & Life Scienceshttps://nadeno.com/

Last Round

Grant

Feb 17, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NaDeNo Nanoscience AS is a biotechnology company developing a nanotechnology drug delivery platform designed to enable direct drug delivery and prolonged retention at tumor sites.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformnanoparticle drug deliverynanomedicinetargeted drug deliverycancer treatmentdrug encapsulationovarian cancerpolymeric nanoparticlescontrolled releasedrug formulationhydrophobic drugsoncologyclinical stage biotechPACA nanoparticles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NaDeNo Nanoscience Comparables

Compare NaDeNo Nanoscience with similar companies based on industry and business-model similarity.

NaDeNo Nanoscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoDrug Delivery GmbH
86%
Cristal Therapeutics
83%
UPyTher B.V.
82%

NaDeNo Nanoscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2026
SeedJan 27, 2023

Key People

Founding team and executive leadership

Annbjørg Eide Falck

Chief Executive Officer

Executive Team

Yrr Mørch

Chief Technology Officer

Executive Team

NaDeNo Nanoscience Investors

Notable investors and investment history

NaDeNo Nanoscience investors
InvestorRounds
European Innovation Council FundGrant
SINTEF VentureSeed
Farvatn VentureSeed
NOMEAccelerator
EIC FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 759% MoM.

  • Feb 17, 2026

    $12M grant received from European Innovation Council.

NaDeNo Nanoscience Filings

Explore SEC and related filing metadata, where available.

NaDeNo Nanoscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NaDeNo Nanoscience's valuation, stock price, and market status.

Is NaDeNo Nanoscience a public or private company?

NaDeNo Nanoscience is a private company.

What is the current stock price of NaDeNo Nanoscience?

NaDeNo Nanoscience is a private company with no public stock price. No recent secondary market data is available.

How much is NaDeNo Nanoscience worth (valuation)?

Valuation information for NaDeNo Nanoscience is not publicly available.

Can I buy NaDeNo Nanoscience stock?

NaDeNo Nanoscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NaDeNo Nanoscience's last funding round?

NaDeNo Nanoscience's most recent funding round was Grant on February 17, 2026.

Who are the main investors in NaDeNo Nanoscience?

Key investors in NaDeNo Nanoscience include European Innovation Council, SINTEF Venture.

Will NaDeNo Nanoscience IPO soon?

No public IPO plans have been announced for NaDeNo Nanoscience.

How can I track NaDeNo Nanoscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NaDeNo Nanoscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTrondheim
Employee Range9
Year Founded2022
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?